A Study to Assess the Impact of Speed and Site of Subcutaneous Injection on Pain, Tolerability, Safety, and Pharmacokinetics of Gantenerumab in Healthy Participants
PHASE1
The purpose of this randomized, open-label, parallel-group, placebo-control...
Status
Completed
Location
PRA International Clinical Pharmacology Center (EDS US Clinic)
A Study Investigating the Bioavailability of a High Concentration Liquid Formulation Versus a Reference Lyophilized Formulation of Gantenerumab in Healthy Volunteers
PHASE1
This single-center, randomized open-label, single-dose, parallel group stud...